BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

24 related articles for article (PubMed ID: 2809158)

  • 1. High serum N-terminal propeptide of procollagen type III concentration is associated with liver diseases.
    Gudowska M; Gruszewska E; Panasiuk A; Cylwik B; Swiderska M; Flisiak R; Szmitkowski M; Chrostek L
    Prz Gastroenterol; 2017; 12(3):203-207. PubMed ID: 29123582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of novel markers of liver disease with neonatal liver disease in premature baboons, Papio sp.
    Keller LM; Eighmy S; Li C; Winter L; Kerecman J; Goodman Z; Mittal N; Blanco CL
    PLoS One; 2020; 15(3):e0228985. PubMed ID: 32150543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-invasive diagnosis of advanced fibrosis and cirrhosis.
    Sharma S; Khalili K; Nguyen GC
    World J Gastroenterol; 2014 Dec; 20(45):16820-30. PubMed ID: 25492996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic fibrosis: are any of the serum markers useful?
    Oh S; Afdhal NH
    Curr Gastroenterol Rep; 2001 Feb; 3(1):12-8. PubMed ID: 11177689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic phosphorus-31 magnetic resonance spectroscopy in primary biliary cirrhosis and its relation to prognostic models.
    Jalan R; Sargentoni J; Coutts GA; Bell JD; Rolles K; Burroughs AK; Taylor Robinson SD
    Gut; 1996 Jul; 39(1):141-6. PubMed ID: 8881826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different response to ursodeoxycholic acid (UDCA) in primary biliary cirrhosis according to severity of disease.
    Floreani A; Zappalà F; Mazzetto M; Naccarato R; Plebani M; Chiaramonte M
    Dig Dis Sci; 1994 Jan; 39(1):9-14. PubMed ID: 8281873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The aminoterminal propeptide of type III procollagen. Studies on physiology and pathophysiology.
    Jensen LT
    Dan Med Bull; 1997 Feb; 44(1):70-8. PubMed ID: 9062765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aminoterminal propeptide of type III procollagen in ovarian cancer. A review.
    Risteli L; Risteli J; Puistola U; Tomás C; Zhu GG; Kauppila A
    Acta Obstet Gynecol Scand Suppl; 1992; 155():99-103. PubMed ID: 1502898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aminoterminal propeptide of type III procollagen and hyaluronan in patients with primary biliary cirrhosis: markers of fibrosis in primary biliary cirrhosis.
    Remmel T; Remmel H; Salupere V
    J Gastroenterol Hepatol; 1996 Nov; 11(11):1016-20. PubMed ID: 8985819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum hyaluronan and aminoterminal propeptide of type III procollagen in primary biliary cirrhosis: relation to clinical symptoms, liver histopathology and outcome.
    Nyberg A; Lindqvist U; Engström-Laurent A
    J Intern Med; 1992 May; 231(5):485-91. PubMed ID: 1602286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type III procollagen peptide: a marker of disease activity and prognosis in primary biliary cirrhosis.
    Babbs C; Smith A; Hunt LP; Rowan BP; Haboubi NY; Warnes TW
    Lancet; 1988 May; 1(8593):1021-4. PubMed ID: 2896870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serial determination of type III procollagen amino propeptide serum levels in patients with histologically progressive and non-progressive primary biliary cirrhosis.
    Beukers R; van Zanten RA; Schalm SW
    J Hepatol; 1992 Jan; 14(1):22-9. PubMed ID: 1737913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Collagen-related markers of bone turnover reflect the severity of liver fibrosis in patients with primary biliary cirrhosis.
    Guañabens N; Parés A; Alvarez L; Martínez de Osaba MJ; Monegal A; Peris P; Ballesta AM; Rodés J
    J Bone Miner Res; 1998 Apr; 13(4):731-8. PubMed ID: 9580479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is measurement of type III procollagen amino propeptide useful in primary biliary cirrhosis?
    Mutimer DJ; Bassendine MF; Kelly P; James OF
    J Hepatol; 1989 Sep; 9(2):184-9. PubMed ID: 2809158
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.